A Case of Pappilary Renal Cell Caircinoma which Responded Well to the Combination Therapy of Ipilimumab and Nivolumab --A CASE REPORT-

We report a case of papillary renal cell carcinoma that responded well to the combination of ipilimumab and nivolumab. The patient was a 68-year-old male who was being followed up for a small left renal mass without treatment. Two years later, computed tomography (CT) showed enlarged cervical and pa...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 68(2022), 4 vom: 31. Apr., Seite 107-111
1. Verfasser: Fukatani, Yusuke (VerfasserIn)
Weitere Verfasser: Daizumoto, Kei, Kadoriku, Fumiya, Yamamoto, Hiraku, Sasaki, Yutaro, Ozaki, Keisuke, Ueno, Yoshiteru, Tuda, Megumi, Kusuhara, Yoshito, Fukawa, Tomoya, Yamamoto, Yasuyo, Yamaguchi, Kunihisa, Takahashi, Masayuki, Kanayama, Hiroomi, Niki, Mariko, Uehara, Hisanori
Format: Online-Aufsatz
Sprache:Japanese
Veröffentlicht: 2022
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Case Reports Journal Article Ipilimumab Nivolumab 31YO63LBSN
LEADER 01000naa a22002652 4500
001 NLM341362913
003 DE-627
005 20231226011614.0
007 cr uuu---uuuuu
008 231226s2022 xx |||||o 00| ||jpn c
024 7 |a 10.14989/ActaUrolJap_68_4_107  |2 doi 
028 5 2 |a pubmed24n1137.xml 
035 |a (DE-627)NLM341362913 
035 |a (NLM)35613898 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a jpn 
100 1 |a Fukatani, Yusuke  |e verfasserin  |4 aut 
245 1 2 |a A Case of Pappilary Renal Cell Caircinoma which Responded Well to the Combination Therapy of Ipilimumab and Nivolumab --A CASE REPORT- 
264 1 |c 2022 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 27.05.2022 
500 |a Date Revised 27.05.2022 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a We report a case of papillary renal cell carcinoma that responded well to the combination of ipilimumab and nivolumab. The patient was a 68-year-old male who was being followed up for a small left renal mass without treatment. Two years later, computed tomography (CT) showed enlarged cervical and para-aortic lymph nodes, and lymph node biopsy suggested metastases of the cancer. After resection of the renal tumor, we performed pararenal aortic lymph node biopsy, and we diagnosed the case as papillary renal cell carcinoma type 1 with lymph node metastasis. The combination of ipilimumab and nivolumab each metastatic site showed regression on CT. Since immune-related adverse events occurred during the therapy nivolumab was discontinued, but partial response of the metastases was maintained 
650 4 |a Case Reports 
650 4 |a Journal Article 
650 7 |a Ipilimumab  |2 NLM 
650 7 |a Nivolumab  |2 NLM 
650 7 |a 31YO63LBSN  |2 NLM 
700 1 |a Daizumoto, Kei  |e verfasserin  |4 aut 
700 1 |a Kadoriku, Fumiya  |e verfasserin  |4 aut 
700 1 |a Yamamoto, Hiraku  |e verfasserin  |4 aut 
700 1 |a Sasaki, Yutaro  |e verfasserin  |4 aut 
700 1 |a Ozaki, Keisuke  |e verfasserin  |4 aut 
700 1 |a Ueno, Yoshiteru  |e verfasserin  |4 aut 
700 1 |a Tuda, Megumi  |e verfasserin  |4 aut 
700 1 |a Kusuhara, Yoshito  |e verfasserin  |4 aut 
700 1 |a Fukawa, Tomoya  |e verfasserin  |4 aut 
700 1 |a Yamamoto, Yasuyo  |e verfasserin  |4 aut 
700 1 |a Yamaguchi, Kunihisa  |e verfasserin  |4 aut 
700 1 |a Takahashi, Masayuki  |e verfasserin  |4 aut 
700 1 |a Kanayama, Hiroomi  |e verfasserin  |4 aut 
700 1 |a Niki, Mariko  |e verfasserin  |4 aut 
700 1 |a Uehara, Hisanori  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Hinyokika kiyo. Acta urologica Japonica  |d 1962  |g 68(2022), 4 vom: 31. Apr., Seite 107-111  |w (DE-627)NLM012631779  |x 0018-1994  |7 nnns 
773 1 8 |g volume:68  |g year:2022  |g number:4  |g day:31  |g month:04  |g pages:107-111 
856 4 0 |u http://dx.doi.org/10.14989/ActaUrolJap_68_4_107  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_20 
912 |a GBV_ILN_22 
912 |a GBV_ILN_40 
912 |a GBV_ILN_60 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_350 
912 |a GBV_ILN_2001 
912 |a GBV_ILN_2003 
912 |a GBV_ILN_2005 
912 |a GBV_ILN_2006 
912 |a GBV_ILN_2008 
912 |a GBV_ILN_2010 
912 |a GBV_ILN_2012 
912 |a GBV_ILN_2018 
951 |a AR 
952 |d 68  |j 2022  |e 4  |b 31  |c 04  |h 107-111